CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 62 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $66,000 | +29.4% | 47,793 | -0.4% | 0.00% | – |
| Q4 2018 | $51,000 | -91.4% | 47,978 | -50.0% | 0.00% | – |
| Q3 2018 | $590,000 | -41.2% | 95,956 | +2.2% | 0.00% | -100.0% |
| Q2 2018 | $1,004,000 | +44.5% | 93,923 | +45.1% | 0.00% | – |
| Q1 2018 | $695,000 | +71.2% | 64,739 | +11.7% | 0.00% | – |
| Q4 2017 | $406,000 | -9.6% | 57,953 | +12.8% | 0.00% | – |
| Q3 2017 | $449,000 | -11.6% | 51,374 | -7.8% | 0.00% | – |
| Q2 2017 | $508,000 | +232.0% | 55,741 | +189.5% | 0.00% | – |
| Q1 2017 | $153,000 | +15.9% | 19,257 | +30.7% | 0.00% | – |
| Q4 2016 | $132,000 | – | 14,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,917,622 | $7,365,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 54,092 | $102,000 | 0.06% |
| Carmignac Gestion | 1,937,608 | $3,643,000 | 0.05% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 91,824 | $173,000 | 0.03% |
| SIGNATUREFD, LLC | 121,351 | $228,000 | 0.01% |
| Tekla Capital Management LLC | 165,330 | $311,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 184,000 | $346,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 567,903 | $1,068,000 | 0.01% |
| Integrated Advisors Network LLC | 15,700 | $30,000 | 0.00% |
| WEDBUSH SECURITIES INC | 22,900 | $43,000 | 0.00% |